Skip to NavigationSkip to content

Pharmafile - Research and Development News

New anti-platelet drug could rival Plavix
Sector will be worth $35bn by 2013, according to new report
CRO reaches milestone with study for AstraZeneca
Committee accused of watering down proposals
Companies will focus on cardiovascular research
Overcapacity is exacerbating the effects of the economic downturn
Phase III breast cancer trial fails to show improvement over Roche's Xeloda
But analysts warn this may not lead to adoption
Company also unveils management restructure
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches